References
- Akuamoa F, Hoogenboom RL, Hamers A, Rietjens IM, Bovee TF. 2021. PDE-5 inhibitors in selected herbal supplements from the Ghanaian market for better erectile function as tested by a bioassay. Toxicol In Vitro. 73:105130. doi:https://doi.org/10.1016/j.tiv.2021.105130
- Ayta IA, McKinlay JB, Krane RJ. 1999. The likely worldwide increase in erectile dysfunction between 1995 and 2025 and some possible policy consequences. BJU Int. 84(1):50–56. doi:https://doi.org/10.1046/j.1464-410x.1999.00142.x
- Bakota EL, Kelly AT, Walterscheid JP, Phatak DR. 2017. A case report of fatal desmethyl carbodenafil toxicity. J Anal Toxicol. 41(3):250–255. doi:https://doi.org/10.1093/jat/bkw128
- Blok-Tip L, Zomer B, Bakker F, Hartog KD, Hamzink M, Ten Hove J, Vredenbregt M, de Kaste D. 2004. Structure elucidation of sildenafil analogues in herbal products. Food Addit Contam. 21(8):737–748. doi:https://doi.org/10.1080/02652030412331272467
- Bujang NB, Chee CF, Heh CH, Rahman NA, Buckle MJ. 2017. Phosphodiesterase-5 inhibitors and their analogues as adulterants of herbal and food products: analysis of the Malaysian market, 2014-16. Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 34(7):1101–1109. doi:https://doi.org/10.1080/19440049.2017.1336674
- Enomoto M, Sakaguchi H, Ominami M, Iwai S, Morikawa H, Tamori A, Kawada N. 2009. Sildenafil-induced severe cholestatic hepatotoxicity. Am J Gastroenterol. 104(1):254–255. doi:https://doi.org/10.1038/ajg.2008.18
- European Medicines Agency. 2008. Summary of product characteristics for sildenafil 2008. http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-ProductInformation/human/000202/WC500049830.pdf
- Gilard V, Balayssac S, Tinaugus A, Martins N, Martino R, Malet-Martino M. 2015. Detection, identification and quantification by 1H NMR of adulterants in 150 herbal dietary supplements marketed for improving sexual performance. J Pharm Biomed Anal. 102:476–493. doi:https://doi.org/10.1016/j.jpba.2014.10.011
- Gratz SR, Flurer CL, Wolnik KA. 2004. Analysis of undeclared synthetic phosphodiesterase-5 inhibitors in dietary supplements and herbal matrices by LC-ESI-MS and LC-UV. J Pharm Biomed Anal. 36(3):525–533. doi:https://doi.org/10.1016/j.jpba.2004.07.004
- Graziano S, Montana A, Zaami S, Rotolo MC, Minutillo A, Busardò FP, Marinelli E. 2017. Sildenafil-associated hepatoxicity: a review of the literature. Eur Rev Med Pharmacol Sci. 21(suppl 1):17–22.
- Gur S, Kadowitz PJ, Gokce A, Sikka SC, Lokman U, Hellstrom WJG. 2013. Update on drug interactions with phosphodiesterase-5 inhibitors prescribed as first-line therapy for patients with erectile dysfunction or pulmonary hypertension. Curr Drug Metab. 14(2):265–269. doi:https://doi.org/10.2174/138920013804870600
- Jiru M, Stranska-Zachariasova M, Dzuman Z, Hurkova K, Tomaniova M, Stepan R, Cuhra P, Hajslova J. 2019. Analysis of phosphodiesterase type 5 inhibitors as possible adulterants of botanical-based dietary supplements: extensive survey of preparations available at the Czech market. J Pharm Biomed Anal. 164:713–724. doi:https://doi.org/10.1016/j.jpba.2018.11.007
- Kee CL, Ge X, Gilard V, Malet-Martino M, Low MY. 2018. A review of synthetic phosphodiesterase type 5 inhibitors (PDE-5i) found as adulterants in dietary supplements. J Pharm Biomed Anal. 147:250–277. doi:https://doi.org/10.1016/j.jpba.2017.07.031
- Kloner R. 2007. Erectile dysfunction and hypertension. Int J Impot Res. 19(3):296–302. doi:https://doi.org/10.1038/sj.ijir.3901527
- Kostis JB, Jackson G, Rosen R, Barrett-Connor E, Billups K, Burnett AL, Carson C, Cheitlin M, Debusk R, Fonseca V, et al. 2005. Sexual dysfunction and cardiac risk (the Second Princeton Consensus Conference). Am J Cardiol. 96(12):85–93. doi:https://doi.org/10.1016/j.amjcard.2005.12.018
- Langtry HD, Markham A. 1999. Sildenafil. Drugs. 57(6):967–989. doi:https://doi.org/10.2165/00003495-199957060-00015
- Lee JH, Min AY, Park OR, Han JH, Yang YJ, Kim H, Baek SY. 2021. Detection of 94 compounds related to sexual enhancement including sildenafil, tadalafil, vardenafil and their analogues in various formulations of dietary supplements and food samples using HPLC and LC-MS/MS. Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 38(5):769–781. doi:https://doi.org/10.1080/19440049.2021.1881623
- Levine LA. 2000. Diagnosis and treatment of erectile dysfunction. Am J Med. 109(9):3–12. doi:https://doi.org/10.1016/S0002-9343(00)00655-0
- Li L, Low MY, Aliwarga F, Teo J, Ge XW, Zeng Y, Bloodworth BC, Koh HL. 2009. Isolation and identification of hydroxythiohomosildenafil in herbal dietary supplements sold as sexual performance enhancement products. Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 26(2):145–151. doi:https://doi.org/10.1080/02652030802368757
- Liu JJ, Li SP, Wang YT. 2006. Optimization for quantitative determination of four flavonoids in Epimedium by capillary zone electrophoresis coupled with diode array detection using central composite design. J Chromatogr A. 1103(2):344–349. doi:https://doi.org/10.1016/j.chroma.2005.11.036
- Low MY, Zeng Y, Li L, Ge XW, Lee R, Bloodworth BC, Koh HL. 2009. Safety and quality assessment of 175 illegal sexual enhancement products seized in red-light districts in Singapore. Drug Saf. 32(12):1141–1146. doi:https://doi.org/10.2165/11316690-000000000-00000
- Mans DJ, Callahan RJ, Dunn JD, Gryniewicz-Ruzicka CM. 2013. Rapid-screening detection of acetildenafils, sildenafils and avanafil by ion mobility spectrometry. J Pharm Biomed Anal. 75:153–157. doi:https://doi.org/10.1016/j.jpba.2012.11.031
- Mateescu C, Popescu AM, Radu GL, Onisei T, Raducanu AE. 2017. Spectroscopic and spectrometric methods used for the screening of certain herbal food supplements suspected of adulteration. Adv Pharm Bull. 7(2):251–259. doi:https://doi.org/10.15171/apb.2017.030
- Matheeussen V, Maudens KE, Anseeuw K, Neels H. 2015. A non-fatal self-poisoning attempt with sildenafil. J Anal Toxicol. 39(7):572–576. doi:https://doi.org/10.1093/jat/bkv071
- Nissan R, Poperno AY, Stein G, Shapira B, Fuchs S, Berkovitz R, Hess Z, Arieli M. 2016. A case of hepatotoxicity induced by adulterated “Tiger King”, a Chinese herbal medicine containing sildenafil. Curr Drug Saf. 11(2):184–188. doi:https://doi.org/10.2174/1574886311207040257.
- Patel DN, Li L, Kee CL, Ge X, Low MY, Koh HL. 2014. Screening of synthetic PDE-5 inhibitors and their analogues as adulterants: analytical techniques and challenges. J Pharm Biomed Anal. 87:176–190. doi:https://doi.org/10.1016/j.jpba.2013.04.037
- Polat DC, Coskun M. 2016. Quantitative determination by HPLC-DAD of icariin, epimedin A, epimedin B, and epimedin C in Epimedium (Berberidaceae) species growing in Turkey. Nat Prod Commun. 11(11):1934578X1601101. doi:https://doi.org/10.1177/1934578X1601101110
- Poon WT, Lam YH, Lai CK, Chan AY, Mak TW. 2007. Analogues of erectile dysfunction drugs: an under-recognised threat. Hong Kong Med J. 13(5):359–363.
- Reeuwijk NM, Venhuis BJ, de Kaste D, Hoogenboom RL, Rietjens IM, Martena MJ. 2014. Active pharmaceutical ingredients detected in herbal food supplements for weight loss sampled on the Dutch market. Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 31(11):1783–1793. doi:https://doi.org/10.1080/19440049.2014.958574
- Rew KT, Heidelbaugh JJ. 2016. Erectile dysfunction. Am Fam Physician. 94(10):820–827.
- Savaliya AA, Shah RP, Prasad B, Singh S. 2010. Screening of Indian aphrodisiac ayurvedic/herbal healthcare products for adulteration with sildenafil, tadalafil and/or vardenafil using LC/PDA and extracted ion LC-MS/TOF. J Pharm Biomed Anal. 52(3):406–409. doi:https://doi.org/10.1016/j.jpba.2009.05.021
- Terrett NK, Bell AS, Brown D, Ellis P. 1996. Sildenafil (VIAGRATM), a potent and selective inhibitor of type 5 cGMP phosphodiesterase with utility for the treatment of male erectile dysfunction. Bioorg Med Chem Lett. 6(15):1819–1824. doi:https://doi.org/10.1016/0960-894X(96)00323-X
- Tucker J, Fischer T, Upjohn L, Mazzera D, Kumar M. 2018. Unapproved pharmaceutical ingredients included in dietary supplements associated with US Food and Drug Administration warnings. JAMA Netw Open. 1(6): e183337. doi:https://doi.org/10.1001/jamanetworkopen.2018.3337
- Venhuis BJ, De Kaste D. 2012. Towards a decade of detecting new analogues of sildenafil, tadalafil and vardenafil in food supplements: a history, analytical aspects and health risks. J Pharm Biomed Anal. 69:196–208. doi:https://doi.org/10.1016/j.jpba.2012.02.014
- Wolfhagen FH, Vermeulen HG, Rob A, Lesterhuis W. 2008. Initially obscure hepatotoxicity attributed to sildenafil. Eur J Gastroenterol Hepatol. 20(7):710–712. doi:https://doi.org/10.1097/MEG.0b013e3282f2bbb5.